The artery of Percheron (AOP) is a rare vascular variant that can cause bilateral paramedian thalamic infarctions when occluded. Due to its atypical clinical presentation and subtle imaging findings, this condition often leads to significant diagnostic challenges. The timely recognition of this condition is critical to implementing appropriate management strategies and improving patient outcomes. We report the case of a 76-year-old man with no prior medical history who presented to the emergency department with a sudden onset of impaired consciousness and vertical gaze palsy. On arrival, the patient was in a state of sleep-like coma. This clinical presentation, combined with the sudden onset of symptoms, was highly suggestive of an AOP infarction. The initial CT findings were unremarkable. Intravenous thrombolysis was administered due to clinical suspicion. The patient demonstrated rapid clinical improvement and regained consciousness in several hours. A follow-up CT scan 24 hours later confirmed bilateral paramedian thalamic infarction, establishing the diagnosis. Although the patient experienced moderate residual cognitive impairment and mild vertical gaze paresis, he regained functional independence within six months. AOP infarction is a rare but serious condition that can present with various symptoms. Its diagnosis can be challenging due to the nonspecific clinical presentation and limitations of conventional imaging techniques in the acute phase, especially in our local context. Early diagnosis and timely intervention, such as intravenous thrombolysis, are crucial to improving functional outcomes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11871939PMC
http://dx.doi.org/10.7759/cureus.78234DOI Listing

Publication Analysis

Top Keywords

clinical presentation
12
bilateral paramedian
8
paramedian thalamic
8
sudden onset
8
vertical gaze
8
aop infarction
8
intravenous thrombolysis
8
clinical
5
time matters
4
diagnosis
4

Similar Publications

Purpose: Medically tailored transitional foods (TFs) may be a clinically viable alternative to pureed consistency for individuals requiring texture-modified foods. However, little remains known about the performance of TFs during the swallow. The purpose of this investigation was to describe oropharyngeal swallowing physiology in patients with dysphagia during consumption of TFs as compared to pureed solids.

View Article and Find Full Text PDF

Herein, a novel and simple electrospray (ES) printing technique was developed for the fabrication of ultrathin graphene layers with precisely controlled nanometer-scale thickness, where graphene oxide (GO) was electrosprayed on wafers and subsequently chemically reduced into reduced GO (rGO). Utilizing that technique, we prepared ultrathin rGO in-plane graphene field-effect transistor (GFET)-based biosensors coupled with a portable prototype measuring system for point-of-care detection of pathogens. We illustrate the use of such prepared GFETs to detect COVID-19, using the SARS-CoV-2 nucleocapsid protein antigen (N-protein) and genomic viral RNA as detection targets.

View Article and Find Full Text PDF

Background: This study aims to analyze the patient characteristics, clinical outcomes, and contemporary trends concerning type A aortic dissection (TAAD) in previous recipients of abdominal solid organ transplantation (ASOT) in the United States.

Methods: The National Inpatient Sample was queried to identify all patients aged ≥18 with TAAD and a history of ASOT (TAAD-ASOT) between 2002 and 2015Q3 using ICD-9 diagnosis and procedure codes. Baseline characteristics and in-hospital outcomes were compared between TAAD-ASOT patients and TAAD patients without a history of ASOT (TAAD-non-ASOT).

View Article and Find Full Text PDF

Background: Infection is a leading cause of death after pediatric heart transplants (PHTs). Understanding of common pathogens is needed to guide testing strategies and empiric antibiotic use.

Methods: We conducted a 3-center retrospective study of PHT recipients ≤18 years old presenting to cardiology clinics or emergency departments (EDs) from 2010 to 2018 for evaluation of suspected infections within 2 years of transplant.

View Article and Find Full Text PDF

The development of targeted therapy for patients with multiple myeloma (MM) is hampered by the low frequency of actionable genetic abnormalities. Gain or amplification of chromosome 1q (1q+) is the most frequent arm-level copy number gain in patients with MM and is associated with higher risk of progression and death despite recent therapeutic advances. Thus, developing targeted therapy for MM patients with 1q+ stands to benefit a large portion of patients in need of more effective management.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!